News

One trial was conducted in type 1 diabetes patients and the other in type 2 patients, both of which compared two ultrafast insulin analog products formulated with rHuPH20

Androderm,a once daily skin patch, called a transdermal delivery system, is a testosterone replacement therapy in males with a deficiency or absence of endogenous testosterone. It delivers consistent,

Euflexxa is a bioengineered, non-avian product which provides relief from osteoarthritis knee pain, especially when simple pain medications such as acetaminophen or from exercise and physical therapy do

Dynavax expects to receive nearly $200m in milestone payments over the term of the alliance. Dynavax and GSK will focus on the development of a TLR8 inhibitor to

XmAb5871, a humanized monoclonal antibody using selective dual-targeting mechanism for B cell inhibition by targeting the antigen CD19 and co-engaging CD32b (Fc?RIIb), helps in suppression of autoimmune response.

DEFINE (Determination of the Efficacy and safety of oral Fumarate IN rElapsing-remitting MS) a global, randomized, double-blind, placebo-controlled, dose-comparison trial enrolled 1,237 patients between 18 and 55 years

ImmuPharma and Cephalon had signed an option agreement in 2008,when the ImmuPharma designed and funded Phase IIb study was ongoing. ImmuPharma was paid $15m by Cephalon before the

Newron will now re-assess all the opportunities for safinamide including re-partnering the compound at some stage. Newron can also pursue marketing of this new chemical entity for Parkinson’s

Modernizing Medicine EMA-Ophthalmology HER featuring a bi-directional communication interface enables a seamless workflow experience across both clinical and financial areas of ophthalmology practice, besides enabling access from anywhere